SCHEMBL6645757

SCHEMBL6645757

Cc1ccc(C2=C(C(=O)Nc3ccc(N(CCn4cccn4)C(=O)OC(C)(C)C)nc3)CCCC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.35
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
F2 P00734 1/20 0.33
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
DGAT1 O75907 4/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
TP53 P04637 1/20 0.32
WNT3A P56704 1/20 0.32
S1PR1 P21453 1/20 0.32
EPHX2 P34913 1/20 0.32
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6647209 0.89 THRB (0.37) THRBKDM4EALDH1A1RXFP1F2
SCHEMBL6643944 0.83 DGAT1 (0.32) DGAT1ADORA3ADORA2A
SCHEMBL6647399 0.80 THRB (0.39) THRBKDM4EALDH1A1RXFP1KMT2A
SCHEMBL6501309 0.80 TP53 (0.34) THRBF2DGAT1ADORA3ADORA2A
SCHEMBL6649510 0.80 HCRTR2 (0.42) THRBKDM4EALDH1A1RXFP1KMT2A
SCHEMBL6647215 0.79 SCD (0.40) KDM4EALDH1A1RAB9A
SCHEMBL6645762 0.78 ADORA3 (0.38) RXFP1KMT2AADORA3ADORA2ATP53
SCHEMBL6645993 0.78 HCRTR2 (0.42) THRBKDM4EALDH1A1RXFP1KMT2A
SCHEMBL6645956 0.77 BRPF1 (0.36) THRBALDH1A1TRPV1DGAT1NPC1
SCHEMBL6646086 0.77 THRB (0.51) THRBKDM4EALDH1A1RXFP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR THRB 340/4885KDM4E 3725/4885ALDH1A1 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.